Table 1 Clinico-pathological features of the analyzed patients

Median age at diagnosis

61.6

Range [Min.-Max.]

40.2 - 79.9

Patients with temozolomide therapy

  Median age at diagnosis

59.2

Patients without temozolomide therapy

  Median age at diagnosis

64.0

Characteristic

Number of patients

% of patients

Age classes

  <50 years

11

17.2

  50 - 60 years

18

28.1

  60 - 70 years

20

31.3

  >70 years

15

23.4

Sex

  Male

39

60.9

  Female

25

39.1

Pathohistology

  Glioblastoma multiforme

64

  Relapses of primary glioblastoma multiforme

17

Therapy

  Only Radiotherapy

11

17.2

  Radiotherapy and temozolomide

45

70.3

  No adjuvant therapy

6

9.4

  No therapy data applicable

2

3.1

Overall survival (OS)

  Median [Days]

459

  Range [Min.-Max.]

34 - 1954

  1-year survival

38

59.4

  2-year survival

9

14.1

OS of patients with temozolomide therapy

  Median [Days]

515

  Range [Min.-Max.]

95 - 1954

OS of patients without temozolomide therapy

  Median [Days]

87

  Range [Min.-Max.]

34 - 701

Vital status at study end (30.06.2009)

  Dead

47

73.4

  Alive

17

26.6